Daily Visitors
Last scanned
Domain Age
Global Rank
Updated:
Autoinflammatory Disease Treatment | ILARIS® (canakinumab)
Learn more about ILARIS® (canakinumab), the once-monthly biologic that may help with SJIA, CAPS, FMF, HIDS/MKD, & TRAPS. See full Prescribing & Safety Info.
This website is hosted with Incapsula Inc, which reserves the following IP addresses for ilaris.com: 45.60.121.251. Moreover, DNS used with this website include a1-254.akam.net, a2-66.akam.net, a24-65.akam.net, a28-67.akam.net, a7-64.akam.net, a9-65.akam.net, dns1.novartis.com, dns2.novartis.com, dns3.novartis.com, dns4.novartis.com. Subnet identifier ranges from 45.60.0.0 to 45.60.255.255. Classless Inter-Domain Routing (CIDR) is 45.60.0.0/16. ARIN net type is Direct Allocation.
Daily Visitors
Last scanned
Domain Age
Global Rank
a1-254.akam.net
a2-66.akam.net
a24-65.akam.net
a28-67.akam.net
a7-64.akam.net
a9-65.akam.net
dns1.novartis.com
dns2.novartis.com
dns3.novartis.com
dns4.novartis.com
{{value}}
1999-12-08
2023-12-08
MarkMonitor Inc.
{{value}}
The registrar of ilaris.com is MarkMonitor Inc. and the name expires on 2023-12-08. According to open source data, you can reach the owner at novartis.domains@markmonitor.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Switzerland, Swiss Confederation.
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
268.8K
890